Invivyd (IVVD) Net Income (QoQ) (2021 - 2025)
Invivyd (IVVD) Net Income (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - |
| 10 | Invivyd | 102.14 Mn | -124.55 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.33% |
| Sep 30, 2025 | 23.18% |
| Jun 30, 2025 | 9.94% |
| Mar 31, 2025 | 7.57% |
| Dec 31, 2024 | 70.48% |
| Sep 30, 2024 | -26.30% |
| Jun 30, 2024 | 37.38% |
| Mar 31, 2024 | -4.04% |
| Dec 31, 2023 | -69.31% |
| Sep 30, 2023 | 17.07% |
| Jun 30, 2023 | -36.51% |
| Mar 31, 2023 | 17.82% |
| Dec 31, 2022 | 9.45% |
| Sep 30, 2022 | 8.95% |
| Jun 30, 2022 | 47.26% |
| Mar 31, 2022 | -33.67% |
| Dec 31, 2021 | 87.13% |
| Sep 30, 2021 | -429.48% |
| Jun 30, 2021 | -214.96% |